\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Deployment: Best use of technologiesThe European Commission has published a new call under the Digital Europe programme (Special Objective 5: Deployment and best use of technologies): European Digital Identity and Trust Ecosystem (Standards and Sample Implementation).
The action aims to support the implementation of the European Digital Identity and Trust Ecosystem and manage the transition between the current and future frameworks supplementing or replacing the current digital service infrastructure (eID) by the EU Digital Identity Wallet framework.
The call foresees support for two successive waves of large-scale pilots to test the deployment of the EU Digital Identity Wallet in priority use cases, including pilots using the European Blockchain Services Infrastructure (EBSI) to support the EU Digital Identity Wallet in cross border use cases, deploying the EU Digital Identity Wallet in national eID ecosystems by Member States. The second round of grants should help enhance technical specifications and implementation guidelines for the wallet and its eco-system and prepare its application in a new range of use cases, enabling it to support interaction with a wide range of public and private services and related attestations.
More information on the call, its objectives, scope and conditions of participation can be found on the Funding & Tenders Portal: DIGITAL-2024-BESTUSE-TECH-06-TRUST
The call is planned to open for submission on 14 May 2024, deadline to submit proposals is 24 September 2024.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
